![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves Generic Version of](https://photos.prnewswire.com/prnfull/20150421/200096)
evaluate the pharmaceuticals company saxenda on glp-1 medications
Shipping Estimate
evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves Generic Version of
USD21.40
USD67.40
Pay in 4 interest-free payments of $5.35 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves Generic Version of](https://cdn.sanity.io/images/0vv8moc6/pharmacytimes/927460ae5e7258b165e8e96356418d0499b1aba4-8192x5464.jpg)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves Generic Version of](https://cdn.sanity.io/images/0vv8moc6/patientcare/052b80bee14aa88c8bc23d0d2186358e8982b16f-674x541.jpg)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves Generic Version of](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2021/09/Image-1-Saxenda-liraglutide-for-the-Treatment-of-Obesity.jpg)
![evaluate the pharmaceuticals company saxenda on glp-1 medications Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in United States FDA Approves Generic Version of](https://siamclinicphuket.com/wp-content/uploads/2025/06/weight-loss-pen.webp)
